vida: research 2026 04 28 #4393

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 06:34:38 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 06:35 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 06:35 UTC*
Member
  1. Factual accuracy — The research journal entry accurately describes the market outcomes for WeightWatchers and Omada Health, the employer mandates for behavioral support, and the direct-to-employer channels launched by Eli Lilly and Novo Nordisk, aligning with the provided inbox sources.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new research journal entry synthesizes information from multiple inbox sources without copy-pasting large paragraphs of evidence.
  3. Confidence calibration — The confidence level for Belief 4 being "SIGNIFICANTLY STRENGTHENED" is appropriate given the strong empirical evidence presented, contrasting the bankruptcy of a behavioral-only company (WeightWatchers) with the profitable IPO of a company integrating physical data (Omada Health).
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file to check for brokenness.
1. **Factual accuracy** — The research journal entry accurately describes the market outcomes for WeightWatchers and Omada Health, the employer mandates for behavioral support, and the direct-to-employer channels launched by Eli Lilly and Novo Nordisk, aligning with the provided inbox sources. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new research journal entry synthesizes information from multiple inbox sources without copy-pasting large paragraphs of evidence. 3. **Confidence calibration** — The confidence level for Belief 4 being "SIGNIFICANTLY STRENGTHENED" is appropriate given the strong empirical evidence presented, contrasting the bankruptcy of a behavioral-only company (WeightWatchers) with the profitable IPO of a company integrating physical data (Omada Health). 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file to check for brokenness. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy:
This PR adds only research journal entries, musings, and source files to inbox/queue/ — no claims are being enriched, so there is no risk of injecting duplicate evidence into existing claims.

3. Confidence:
No claims are modified or created in this PR (only research journal, musings, and sources), so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims — no broken wiki link syntax detected.

5. Source quality:
The inbox/queue/ files reference specific companies (WeightWatchers bankruptcy May 2025, Omada IPO June 2025, Noom biomarker testing December 2025, Eli Lilly/Novo Nordisk DTE March/January 2026) and payer statistics (34% employer mandate, Evernorth 9M lives) — these are verifiable commercial events and would constitute credible sources if converted to claims.

6. Specificity:
No claims are being modified or created in this PR — the research journal entries contain specific falsifiable assertions (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") but these are research notes, not formal claims subject to specificity requirements.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This PR adds only research journal entries, musings, and source files to inbox/queue/ — no claims are being enriched, so there is no risk of injecting duplicate evidence into existing claims. **3. Confidence:** No claims are modified or created in this PR (only research journal, musings, and sources), so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken [[links]] to KB claims — no broken wiki link syntax detected. **5. Source quality:** The inbox/queue/ files reference specific companies (WeightWatchers bankruptcy May 2025, Omada IPO June 2025, Noom biomarker testing December 2025, Eli Lilly/Novo Nordisk DTE March/January 2026) and payer statistics (34% employer mandate, Evernorth 9M lives) — these are verifiable commercial events and would constitute credible sources if converted to claims. **6. Specificity:** No claims are being modified or created in this PR — the research journal entries contain specific falsifiable assertions (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B)") but these are research notes, not formal claims subject to specificity requirements. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 06:35:44 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 06:35:44 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 06:38:19 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.